NeuroVasx offers cPAX, a polymer strand delivered through a micro catheter, for the minimally invasive treatment of hemorrhagic and ischemic strokes, as well as for embolization of cerebral and intracranial aneurysms. Their products are used to treat acute stroke and other cerebrovascular disorders. Founded in 1997 and based in Maple Grove, Minnesota, NeuroVasx aims to develop and commercialize unique technologies and methodologies to improve the treatment and long-term care of stroke patients.